HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC PROCEDURE FOR THE DETERMINATION OF PROBUCOL IN HUMAN-PLASMA

被引：18

作者：

KUDO, S ^{[1
]}

AKIYAMA, H ^{[1
]}

ODOMI, M ^{[1
]}

MIYAMOTO, G ^{[1
]}

机构：

[1] OTSUKA PHARMACEUT CO LTD,TOKUSHIMA RES INST,DRUG METAB & ANALYT RES LABS,463-10 KAGASUNO,KAWAUCHI,TOKUSHIMA 77101,JAPAN

来源：

JOURNAL OF CHROMATOGRAPHY | 1983年 / 277卷 / OCT期

关键词：

D O I：

10.1016/S0378-4347(00)84869-0

中图分类号：

O65 [分析化学];

学科分类号：

070302 ; 081704 ;

摘要：

引用

页码：419 / 422

页数：4

共 9 条

[1]

BARNHART JW, 1970, AM J CLIN NUTR, V23, P1229

[2] OVERVIEW OF BIOCHEMICAL PHARMACOLOGY OF PROBUCOL [J].

BARNHART, JW ;

RYTTER, DJ ;

MOLELLO, JA .

LIPIDS, 1977, 12 (01) :29-33

[3]

COLMORE J, 1969, AM SOC CLIN PHARM TH

[4] EFFECT OF [4,4'-(ISOPROPYLIDENEDITHIO)BIS(2,6-DI-T-BUTYLPHENOL)] (DH-581) ON SERUM LIPIDS AND LIPOPROTEINS IN HUMAN SUBJECTS [J].

DRAKE, JW ;

BRADFORD, RH ;

MCDEARMON, M ;

FURMAN, RH .

METABOLISM, 1969, 18 (11) :916-+

[5]

HEEG JF, 1980, NOUV PRESSE MED, V9, P2290

[6] PROBUCOL - REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC USE IN PATIENTS WITH HYPERCHOLESTEROLEMIA [J].

HEEL, RC ;

BROGDEN, RN ;

SPEIGHT, TM ;

AVERY, GS .

DRUGS, 1978, 15 (06) :409-428

[7]

KALAMS Z, 1971, CURR THER RES CLIN E, V13, P692

[8]

KRITCHEVSKY D, 1971, FED P FED AM SOC EXP, V30, P692

[9]

TACHIZAWA H, COMMUNICATION

← 1 →